Regular Supplier Of Stents Ignored By Doctors Due To Low Commission; Company Supplying Despite Crores Of Dues

THIRUVANANTHAPURAM: Although the agencies have stopped the supply of cardiac surgery materials including stents to government hospitals, the doctors are ignoring the company that still provides the materials without delay. Doctors are ignoring Medtronic, a company in Ireland that delivers the goods directly.

Even though the government has to pay crores of dues to them, the withdrawal of suppliers has not affected them as the company supplies the goods directly. It is reported that doctors are not promoting their materials as the commission they give is less than other agencies. This company is providing Stent, Catheter, Balloon, Pacemaker etc. at the Karunya Arogya Suraksha Padhathi rates set by the government.

All hospitals including medical colleges have Medtronic’s products in stock. The company is also ready to deliver on request. Medtronic provides supplies 24 hours a day across the state including Thiruvananthapuram Medical College. The publicity that despite all this the stent was out of stock and the surgery was cancelled due to the withdrawal of regular suppliers, caused panic among the poor waiting for the surgery. Many people call the cardiology department daily to inquire whether the surgery will be done.

12 surgeries today in medical college

12 previously scheduled surgeries were performed in two cath labs today in Thiruvananthapuram Medical College. Facilities were also provided for four emergency cases.

Sree Chitra stent in final stage

The stent, developed by the Department of Biomedical Technology at Sree Chitra Institute through years of research, is in its final stages. Animal testing has been completed and a patent has been received. Expressions of Interest are invited for transfer of technology to manufacture stents on an industrial basis. Dr Sujesh Sreedharan, who led the research, said that the company will be selected soon and the technology will be transferred. After completing the human trials and obtaining approvals, it will be brought to the market. The stent is expected to reach the market within two years. The aim is to provide quality stents at low cost. Other team members are Dr ER Jayadevan, Dr M Unnikrishnan and Dr CV Muralidharan. The price will be decided by the company that manufactures the stent.

Related Posts

  • Pharma
  • May 25, 2024
  • 64 views
NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling price of asthma inhaler drug combination formoteral 6 mcg and budesonide 400 mcg dry power inhaler (DPI) under…

  • Pharma
  • May 25, 2024
  • 75 views
Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Jaipur: To provide quality education in pharmacy institutes, the central government has prepared to end the duplicate system. Strict action will be taken against fake students and teachers in newly opened…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

A Doctor diagnoses Mood of Voters in Delhi

A Doctor diagnoses Mood of Voters in Delhi

NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Ex-Pharmacy Council Registrar Gave Certificates To Ineligible Candidates?

Ex-Pharmacy Council Registrar Gave Certificates To Ineligible Candidates?

Experts Call For Ethical Standards, Patient Advocacy In Clinical Research

Experts Call For Ethical Standards, Patient Advocacy In Clinical Research